Aptevo Therapeutics Inc (NASDAQ: APVO) is -98.23% lower on its value in year-to-date trading and has touched a low of $0.14 and a high of $21.56 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The APVO stock was last observed hovering at around $0.15 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.14, the stock is -15.83% and -51.85% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.93 million and changing -2.96% at the moment leaves the stock -94.30% off its SMA200. APVO registered -99.16% loss for a year compared to 6-month loss of -81.97%. The firm has a 50-day simple moving average (SMA 50) of $0.29334 and a 200-day simple moving average (SMA200) of $2.475625.
The stock witnessed a -60.21% gain in the last 1 month and extending the period to 3 months gives it a -57.85%, and is -14.27% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.10% over the week and 14.59% over the month.
Aptevo Therapeutics Inc (APVO) has around 40 employees, a market worth around $1.33M and $0.00M in sales. Distance from 52-week low is 0.79% and -99.35% from its 52-week high. The company has generated returns on investments over the last 12 months (-263.01%).
The EPS is expected to shrink by -94.84% this year.
Aptevo Therapeutics Inc (APVO) Top Institutional Holders
20.0 institutions hold shares in Aptevo Therapeutics Inc (APVO), with institutional investors hold 14.62% of the company’s shares. The shares outstanding are 9.42M, and float is at 9.42M with Short Float at 0.62%. Institutions hold 14.61% of the Float.
Aptevo Therapeutics Inc (APVO) Insider Activity
#####
